During the past decade, Physicians Protocol conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Physicians Protocol" #1 sponsor was "Refocus Group, Inc." with 2 trials, followed by "AcuFocus, Inc." with 1 trials sponsored, "FORSIGHT Vision3" with 1 trials sponsored, "Nidek Co. LTD." with 1 trials sponsored and "PresbiBio, LLC" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "Physicians Protocol" are "Presbyopia" (4 trials), "Cataract" (2 trials), "Aphakic Eye" (1 trials), "Dry Eye Disease" (1 trials) and "Eyes With Corneal Abnormality" (1 trials). Many other conditions were trialed in "Physicians Protocol" in a lesser frequency.

Most popular intervention types in "Physicians Protocol" are "Device" (5 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Betamethasone Sodium Phosphate 0.01%" (1 trials), "Control Group" (1 trials), "Corneal inlay" (1 trials), "Cyclosporine 0.05% Ophthalmic Emulsion" (1 trials) and "Eye Shield" (1 trials). Other intervention names were less common.

The vast majority of trials in "Physicians Protocol" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Physicians Protocol". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 5 completed trials in Physicians Protocol, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Physicians Protocol, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".